ArticleInternational journal of general medicine2025
Impact of Active Surveillance on Nephrometric Scores of Bosniak III and IV Renal Cysts.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Active surveillance (AS) has been widely explored for small renal masses, but its role in complex renal cysts (CRCs) categorized as Bosniak (Bk) III and IV remains unclear. This study aims to evaluate changes in nephrometry scores (s-RENAL and s-PADUA) during AS and their potential impact on surgical complexity. Methods: A retrospective, multicentric, observational study was conducted, analyzing 101 CRCs from 95 patients across three institutions. Nephrometry scores were evaluated at baseline and after a minimum follow-up of two years using computed tomography (CT) and magnetic resonance imaging (MRI). Statistical analysis included chi-square and marginal homogeneity tests, with data managed using REDCap. Results: Among the 101 CRCs, 39 were Bk IV and 62 Bk III, with a mean follow-up of 4.2 years. The initial mean lesion size was 2.77 cm (0.50-11.8 cm), increasing to 3.0 cm (0.40-13.10 cm) at follow-up. Complexity scores increased in 4% of cases according to s-RENAL and 5% according to s-PADUA. Tumor growth was observed in 45 cases (44.5%), while 37 (36.6%) remained stable, and 19 (18.8%) decreased in size. Bk IV cysts tended to increase in size more than Bk III and had a smaller chance of decreasing. Median growth and shrinkage velocities were 0.19 cm/year and 0.21 cm/year, respectively. Conclusion: Active surveillance is a viable and safe strategy for managing select Bk III and IV CRCs. A small but significant proportion of CRCs under AS exhibit increased nephrometry complexity, which may impact surgical planning. These findings suggest that nephrometry score evolution should be considered when selecting patients for AS versus early surgical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.